Motilal Oswal has initiated coverage on Tata Capital with a 'Neutral' rating and a target price of Rs 390, implying an 8% upside from curre...

Any long-term investor knows that corrections are part of every bull run. But it is important that they be aware whether the correction is ...

Indian equities ended lower, snapping a two-day rally as escalating Iran-US tensions and profit booking weighed on sentiment. Sensex fell 3...

Analysts at Nomura and Jefferies, however, maintain 'Buy' ratings, with Nomura highlighting Anup Kumar Saha as a strong internal candidate....

Indian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommen...

At this point, it would be good to keep some powder dry and focus on the fundamentals of sectors, especially those where underlying changes...

India might need to boost rice-based ethanol production for E20 fuel blending by 2026-27. El Nino's impact on sugarcane and maize crops cou...

SpaceX is reportedly planning a direct-to-consumer Starlink mobile service in the US, potentially challenging giants like Verizon and AT&T....

Many companies in this space have underperformed the broader market. The underperformance did not happen without reason. Margins were under...

India's economic strength, not AI's decline, will drive foreign capital inflows, according to Sameer Dalal. He believes AI's market correct...

Happy Wednesday! Meta just handed WhatsApp’s steering wheel to Cred’s Kunal Shah, betting he can turn India’s favourite chat app into a pay...

Indian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRC...

Mamaearth's parent company, Honasa Consumer, is acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This stra...

Honasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...

Honasa Consumer, parent of Mamaearth, is acquiring a 58% stake in nutraceuticals firm Fluence Pharma for Rs 135 crore, marking its entry in...

Digital infrastructure firm ITG is aiming for a valuation of up to $2.67 billion in its US stock market debut, seeking to raise as much as ...

Honasa Consumer shares surged after the company outlined a revenue target of ₹5,500 crore by FY31. The guidance implies an annual growth ra...